The nurse is giving a child in chronic renal failure an injection of erythropoietin (Epogen). The mother of the child asks about the purpose of this drug. What information about the drug should the nurse give to the mother?

1. A

   Erythropoietin decreases inflammation.

2. B

   Erythropoietin removes excess potassium from the blood.

3. C

   Erythropoietin boosts linear growth.

4. D

   Erythropoietin combats anemia.

Appeared in: NORCET-7 Mains-2024

Explanation

Listen in Hindi

• The primary function of erythropoietin (EPO) is to stimulate the bone marrow to produce red blood cells (erythropoiesis).
• In chronic renal failure, the damaged kidneys are unable to produce sufficient amounts of endogenous erythropoietin.
• This lack of EPO leads to a specific type of anemia, known as anemia of chronic disease.
• Administering synthetic erythropoietin (epoetin alfa, or Epogen) replaces the deficient hormone, stimulating red blood cell production and thus combating anemia.
• Treatment with erythropoiesis-stimulating agents (ESAs) like Epogen can reduce the need for blood transfusions and improve the quality of life for patients with chronic kidney disease.

Why Other Options Were Wrong

• Option A: Erythropoietin does not have anti-inflammatory properties. Its primary role is hormonal signaling for red blood cell production.
• Option B: Erythropoietin does not affect potassium levels. Hyperkalemia (high potassium) is a separate, serious complication of renal failure.
• Option C: Erythropoietin does not directly stimulate linear growth. While anemia can contribute to poor growth, EPO's function is not growth promotion.

Related Visual

• Visual 1: Diagram: Pathophysiology of Anemia in Chronic Kidney Disease. This visual would show a healthy kidney producing EPO to stimulate the bone marrow, contrasted with a failing kidney producing insufficient EPO, leading to anemia.
• Visual 2: Flowchart: Treatment of CKD Complications. This could illustrate the different problems arising from CKD (anemia, hyperkalemia, bone disease, growth failure) and the specific treatment for each, clarifying why EPO is used for anemia and other drugs are used for other issues.

Clinical Relevance

• Nursing practice connection: Use the key finding related to Pharmacology and Pathophysiology of Anemia in Chronic Renal Failure to guide bedside assessment, documentation, and the next nursing action.
• Patient education is a critical nursing responsibility. Explaining the purpose of medications in simple terms, as in this scenario, improves adherence and empowers families.
• Nurses administering erythropoietin must monitor for potential side effects, most notably hypertension and thromboembolic events. Blood pressure should be checked before each dose.
• Monitoring treatment effectiveness involves checking hemoglobin and hematocrit levels. The dose is titrated to a target hemoglobin level (typically 10-12 g/dL) to avoid risks associated with overly high levels.

How to Approach the Question

• First, identify the patient's primary diagnosis: chronic renal failure (CRF).
• Recall the major functions of the kidneys. Beyond filtration, they produce hormones, including erythropoietin.
• Consider the consequences of CRF. The term 'failure' implies these functions are impaired.
• Connect the impaired kidney function to the drug being administered. The kidneys fail to produce erythropoietin.
• Recall the function of erythropoietin: it stimulates red blood cell (RBC) production.
• Therefore, a lack of erythropoietin leads to a lack of RBCs, which is the definition of anemia. The drug must be for treating anemia.

Concept Tested & Keywords

• Concept Tested: Pharmacology and Pathophysiology of Anemia in Chronic Renal Failure
• Stem keywords: child, chronic renal failure, erythropoietin, Epogen, purpose of drug
• Lead-in keywords: What information
• Clinical cues: Patient has chronic renal failure, which points to a kidney-related complication.
• Clinical cues: The drug is erythropoietin, directly linking to red blood cell production.

Question ID

QacbQErVB8TF75w5oLbjkV

Copy ID